of giant macromolecules and their physical and chemical states are highly important in health and disease.
The acidic mucopolysaccharides, as their name implies, are a group of 2-amino-2-deoxyhexose-containing polysaccharides that are characterized by their acidic natures and ability to form salts. These properties are afforded by carboxyl functions of constituent uronic acid residues and/or by sulphate ester and sulphamide groups. Thus these polysaccharide materials are quite distinct from the polysaccharide/oligosaccharide moieties of the broad spectrum of glycoproteins that contain 2-amino-2-deoxyhexose but in which acidic characteristics of the carbohydrate are provided by residues of derivatives of neuraminic acid, uronic acid being absent. The acidic mucopolysaccharides are also distinct from the polyuronic acids (e.g. alginates), which contain no 2-amino-2-deoxyhexose, from poly-(2-acetamido-2-deoxy-~-glucose) (chitin), which contains no acidic groups, and from sulphated polyglycans (e.g. carrageenans), which contain neither 2-amino-2-deoxyhexose units nor carboxyl groups.
In the interests of systematization, the term 'glycosaminoglycan' i s now used to VOl. 1 Table 1 , along with earlier, now incorrectly used, names.
BIOCHEMICAL SOCIETY TRANSACTlONS

Occurrence
Hyaluronic acid, the first reported glycosaminoglycan, was originally extracted in a crude form from human umbilical cords as Wharton's Jelly (Wharton, 1656) . The glycosaminoglycan is also a component of synovial fluid, vitreous humour, skin, connective tissue, aorta etc., and is produced by a few bacteria. Chondroitin 4-sulphate was first isolated in 1861 from cartilage (Fischer & Boedeker, 1861), whereas chondroitin 6-sulphate was not recognized until 1936 (Meyer & Palmer, 1936) . The two isomers have also been isolated from bone, cornea, aorta, umbilical cord, connective tissues etc. They usually occur together, although either may be predominant. Chondroitin polysulphates have been isolated from squid and shark cartilage. Chondroitin has a more limited occurrence and was first isolated in 1953 from bovine cornea (Meyer et al., 1953) . Dermatan sulphate was originally extracted in 1941 from pig skin (Meyer & Chaffee, 1941) and has since been recognized in cornea, sclera, lung, aorta and connective tissues. Small quantities of the polysaccharide have recently been identified in a bacterium (Clostridium welchii) (Darby et al., 1970) , and this would appear to be the first reported bacterial source of L-iduronic acid.
Heparin is the remarkable blood coagulant that is prepared on a commercial scale from mammalian gastric mucosa etc., and its properties and wide distribution in animal tissues have given rise to an enormous amount of literature since its discovery in 1916 (McLean, 1916) . Heparan sulphate, like chondroitin, is one of the more recently discovered glycosaminoglycans (Jorpes & GardeIl, 1948) , and has now been found in liver, lung, skin and connective tissue. Keratan sulphate was first isolated in 1953 from bovine cornea (Meyer et al., 1953) . It has also been recognized in bone, cartilage and aorta, and polysulphated varieties have been isolated from shark cartilage.
Many of the known sources of glycosaminoglycans are being reinvestigated for the occurrence of the less common chondroitin and heparan sulphate, and new sources of glycosaminoglycans, e.g. marine invertebrates, are frequently reported.
Primary structure
The glycosaminoglycans are distinguishable by the primary structures of their basic repeating units. Minor variations in these repeating units have been identified in many cases, and are discussed below, but the general structures are given now to facilitate classification (see Table 2 ). The repeating unit of hyaluronic acid is structure (1) and the molecule contains no sulphate, whereas chondroitin, the only other not sulphated glycosaminoglycan, has the repeating structure (2) and is therefore an isomer of hyaluronic acid, the 2-amino-2-deoxyhexose units having the D-galacto and the D-ghC0 configuration respectively. As implied, chondroitin 4-sulphate and chondroitin 6- 
sulphate are sulphated variants of chondroitin, the sulphate ester group occurring on the 2-amino-2-deoxy-~-ga~actose residues [structures (3) and (4)]. Dermatan sulphate is an isomer of chondroitin 4-sulphate in which the D-glUCurOniC acid residue is replaced by its C-6 epimer, L-iduronic acid [structure (S)].
The structures of the repeating units of heparin, heparan sulphate and keratan sulphate have been continually revised, but it has been established that they involve the following: heparin, structures (6) and (7) (Perlin et at., 1971 ; Helting & Lindall, 1971) ; heparan sulphate-O-hexopyranosyl-(2-acetamido-2-deoxy-~-glucose), in which the 2-acetamido-2-deoxy-~-glucose units are N-sulphated and less frequently 0-sulphated (Cifonelli & King, 1970; Dietrich et al., 1971) ; keratan sulphate, structure (8), in which both monosaccharide units may bear 6-sulphate residues (Bhavanandan & Meyer, 1967 , 1968 .
Although these basic repeating structures hold good in a general way, it must never be imagined that the polysaccharide chains are built up from perfect repetitions of these structures. As with othei polysaccharides, several workers have observed irregularities to small extents in many of these polysaccharides. For example, the application of chondroitin sulphate lyases andchondrosulphatases has revealed that occasionally the repeating disaccharide of the chondroitin sulphates may be di-or non-sulphated (Murata et al., 1971) and that the L-iduronic acid units of dermatan sulphate may bear a sulphate group in addition to the normal sulphate group on the 2-amino-2-deoxyhexose unit (Suzuki et a/., 1968). Dermatan sulphate is largely resistant to testicular hyaluronidase, but can break partially owing to the presence of a few D-glucuronic acid residues (Fransson & RodCn, 1967a,h) . Dermatan sulphate-chondroitin sulphate co-polymers have been isolated and contain equimolar proportions of the three repeating disaccharide units (3), (4) and ( 5 ) (Fransson & Haksniark, 1970) .
The structure of heparin has received a tremendous amount of attention, being made complex by the variable degrees of sulphation and the random locations of the groups. Much controversy has arisen over the configuration of the uronic acid units, the D-gliico form having been proposed originally. However, L-iduronic acid has been isolated from pure heparin via mild acid hydrolysis (Wolfrom et al., 1969u) , additional experiments establishing that it was derived neither fromcontaminant dermatan sulphatenor through C-5 epimerization of D-glucuronic acid. Sulphation of the 2-amino-2-deoxy-~-g~ucose residues is claimed to occur mostly at C-6 (Wolfrom et ul., 19696), whereas the uronic acid residues are not sulphated in the normal repeating unit. However, some Dglucuronic acid residues are sulphated, and non-sulphated 2-amino-2-deoxy-~-g~ucose and 2-amino-2-deoxy-~-g~ucose 3,6-disulphate residues occur in small proportions (Danishefsky et al., 1969) .
Nitrous acid degradation (Cifonelli, 1968) and enzymic hydrolysis (Linker & Hovingh, 1968) of heparan sulphate have led to the suggestion of some basic monosaccharide sequences. Although keratan sulphate is generally assumed to contain galactose as its constituent hexose, it is frequently reported to contain fucose, sialic acid and particularly mannose (Toda & Seno, 1970) , some of the hexose units being non-sulphated (Hirano & Meyer, 1971 ).
Attachment to protein
Although it was noted back in 1889 that chondroitin sulphate occurs in the natural state in association with protein (Morner, 1889) , it was not realized at that time that the protein and glycosaminoglycan are covalently linked. The removal of protein was considered an essential part of the purification of glycosaminoglycans, but more recently the proteinaceous counterparts of glycosaminoglycans have been investigated in great detail. A common glycopeptide linkage sequence [structure (9)] has been found for chondroitin 4-sulphate and heparin (Lindahl, 1966; Lindahl & Roden, 1966) , chondroitin 6-sulphate (Helting & Roden, 1968) and dermatan sulphate (Bella & Danishefsky, 1968; Stern et al., 1969) , whereas the linkage of keratan sulphate involves structure (10) (Stuhlsatz eta/., 1971) .
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The overall picture for the protein complexes of the glycosaminoglycans is one of complexity, and it is now clear that a particular protein backbone or core may bear more than one type of pendant polysaccharide. For example, chondroitin 4-sulphate and keratan sulphate are frequently found to occur together in this way (Lyons & Singer, 1971 ; Brandt & Muir, 1971) , and the complete glycosaminoglycan-protein molecule is termed a proteoglycan. Clearly the proteoglycans contribute extensively to tissue structure in their association with collagen and also to the viscoelastic and shock-resistant properties of joint fluids. Studies of the physicochemical properties of the proteoglycans and glycosaminoglycans by, e.g., sedimentation analysis and X-ray crystallography are leading to rationalization of their structures in terms of their functions.
Identification
Originally, the structures of the glycosaminoglycans were determined by laborious, classical carbohydrate chemistry carried out on relatively large scales. More recently workers have relied on comparison of the component analyses and chromatographic data of the unknowns with those obtained for 'standard preparations'. However, many of the newly found sources yield glycosaminoglycans in very small amounts, and an additional problem to the scale of working is that the source itself may not be readily available in large quantities. For this reason minor glycosaminoglycan components of a number of sources have only been tentatively identified or even overlooked.
Numerous techniques, including electrophoresis and ion-exchange chromatography, have been employed for the separation of the glycosaminoglycans, although no one method separates them all. The cetylpyridinium chloride-cellulose column technique (Svejcar & Robertson, 1967 ) is probably one of the best, being based on the fact that glycosaminoglycans can be largely separated by precipitation as their cetylpyridinium salts (Scott, 1960) . Gel filtration is useful in purification, although problems may arise through association with the gel matrix (Kennedy, 1972~) .
However, the only completely satisfactory method of individual identification and measurement is one based on structural recognition. New methods for the micro-scale chemical identification of hyaluronic acid, chondroitin, chondroitin 4-sulphate, chondroitin 6-sulphate and dermatan sulphate have therefore been elucidated (Barker et al., 19686) . Hyaluronic acid is degraded with hyaluronidase, the products being further degraded with p-D-glucuronidase and p-D-acetamidodeoxyglucosidase to a characteristic disaccharide (1 1). Chondroitin 4-sulphate, chondroitin 6-sulphate and dermatan sulphate are distinguished with hyaluronidase and treated with chondroitin sulphate lyases and chondrosulphatases from Proteus vulgaris to give a sulphate-free unsaturated disaccharide (12), which with periodate gives a characteristic oxidation product, @-formylpyruvate. The positions of linkages in the disaccharides may be established by specific photometric analysis. Component analyses are combined with these specific methods, and new sensitive techniques have been reported for the determination of sulphate by flame photometry (Barker et al., 1968a) and the characterization and quantitative determination of the 2-amino-2-deoxyhexoses by fluorimetry (Cho Tun et a[., 1969) . Altogether, these combined techniques, specific for the identification and characterization of the glycosaminoglycans named, require only 150pg total of each polysaccharide.
The chondroitin sulphate lyases and the chondrosulphatases have also been applied to chondroitin sulphates and dermatan sulphate by others Saito et al., 1968) to differentiate between the three isomeric glycosaminoglycans and thereby provide a means of partial structural recognition by chromatographic comparison of the products with standards. These enzymes are now commercially available in small quantities.
The quantitative isolation of glycosaminoglycans for identification frequently presents a problem, their association with insoluble collagen fibres etc. being very strong. Various techniques have been employed, but it is clear that extensive disruption of the fibres is essential (Barker et al., 1969a ). However, it is possible that some tissues contain VOl. 1 sub-microgram amounts of glycosaminoglycans, and therefore these cannot be identified by the micro-scale techniques. Specific incorporation of radioactively labelled precursors during tissue culture has been used to label the glycosaminoglycans (Barker et al., 19696) , subsequent separation and counting of radioactivity (Kennedy, 1969) being used to identify the polysaccharides at the sub-microgram level. Such incorporative studies are also of use as test systems for the testing of drugs etc. for their action and side effects on the structure, biosynthesis and metabolism of tissue (Barker & Kennedy, 1969~) .
Glycosaminoglycans arid clinical conditions
Diseases involving glycosaminoglycans have been investigated extensively, the muco- Although clinical distinction between the five or more forms of mucopolysaccharidoses themselves is not too difficult, the symptoms are often disguised owing to the presence of other abnormalities. A chemically based diagnosis is required, and many qualitative and quantitative tests have been applied : a test paper has become commercially available this year. Research in this area is aimed at producing reproducible qualitative screening tests and methods of analysis (Lewis et al., 1973) , including identification on the basis of chemical structure (Kennedy et d., 1970) .
As might be expected from their importance in tissue structure and body fluid, the involvement of glycosaminoglycans in disease is certainly not confined to the mucopolysaccharidoses. Abnormalities occur in many other conditions, including skin diseases (Moynahan & Kennedy, 1966 , 1968 Barker & Kennedy, 1969b) , rheumatoid arthritis (Barker &Young, 1966; How &Long, 1969) and ocular disorders (Barker efnl., 1968~). Apart from analyses of the degenerate glycosaminoglycan molecules, structural studies are being directed towards identification of the mechanisms by which the glycosaniinoglycans become degraded in disease (Kennedy & Cho Tun, 1972) .
Conclusion
Enormous effort is currently being put into research on the glycosaminoglycans and proteoglycans, and several hundred papers are published annually on the chemical, chemicomedical and biosynthetic aspects. Current awareness is facilitated by an annual review ofsuch papers (Kennedy, 1971 (Kennedy, ,19726,1973 , and the interest in the field in Britain alone justified the formation of the Mucopolysaccharide Club in 1966.
The results of the recent extensive work on glycosaminoglycans guarantee continued activity in the field. Hopefully, as the structures of both carbohydrate and protein are further investigated, the agents that cause their abnormal bioqynthesis and breakdown in clinical conditions and means of counteracting their effects will be discovered. The whole field of glycosaminoglycans therefore undoubtedly holds great potential for further discoveries of the processes involved in health and disease and for increased collaboration between the chemist, biochemist and clinician.
